Relationship between chromosomal aberrations and gene expressions in the p53 pathway in chronic lymphocytic leukemia

Chronic lymphocytic leukemia (CLL) is a neoplasm characterized by excessive accumulation of B lymphocytes in the peripheral blood, bone marrow and lymph nodes. We assessed the expressions of 22 genes in the p53 pathway in 30 CLL patients and 15 healthy subjects by a RT2 Profiler PCR (polymerase chai...

Full description

Saved in:
Bibliographic Details
Published inBalkan journal of medical genetics Vol. 23; no. 1; pp. 15 - 24
Main Authors Öztan, G, Aktan, M, Palanduz, S, İşsever, H, Öztürk, S, Nikerel, E, Uçur, A, Bağatir, G, Bayrak, A, Çefle, K
Format Journal Article
LanguageEnglish
Published Sofia Sciendo 26.08.2020
De Gruyter Poland
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Chronic lymphocytic leukemia (CLL) is a neoplasm characterized by excessive accumulation of B lymphocytes in the peripheral blood, bone marrow and lymph nodes. We assessed the expressions of 22 genes in the p53 pathway in 30 CLL patients and 15 healthy subjects by a RT2 Profiler PCR (polymerase chain reaction) Array technique and their relation to cytogenetic aberrations detected by fluorescent hybridization (FISH). Our Student’s -test results indicated that and BCL2 genes were statistically significant ( <0.001). For six genes and were not statistically significant. The and genes were found to be upregulated by the 2 (relative fold change in gene expression) method. The highest up-regulation was detected in and genes, 10.22- and 8.51-fold, respectively. On the other hand, the gene with a fold regulation of 1.84 was found to the highest downregulation. Overall, the and genes are related to the mechanism of the disease in the p53 pathway and may be an important predictor of the prognosis of the disease. The gene may be associated with increased risk of developing CLL. We suggest that the gene may be considered as a marker associated with CLL disease. The gene expression seems to play a protective role in CLL.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ISSN:1311-0160
1311-0160
2199-5761
DOI:10.2478/bjmg-2020-0007